Skip to content
Therapy But Better – Lifestyle
Author:
Quantum BioPharma
Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied
April 2, 2026
Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis
April 1, 2026
Quantum BioPharma Provides Corporate Update
March 11, 2026
←
Previous Page
1
2